-
Analysis of four key cell types (epithelial, fbroblast, myeloid and T cells)
Study
EGAS00001003579
-
Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma
Study
EGAS00001003564
-
Mesothelioma_Whole_Genomes
Study
EGAS00001000830
-
Study of pediatric hepatocellular carcinoma caused by bile salt export pump deficiency
Study
EGAS00001000749
-
Genomic analysis of Smoothened inhibitor resistance in basal cell carcinoma
Study
EGAS00001000845
-
Human_primary_melanoma_project
Study
EGAS00001002409
-
Angiosarcoma_whole_exome
Study
EGAS00001000588
-
Frequent alterations in cytoskeleton remodeling genes in primary and metastatic Chinese lung adenocarcinomas
Study
EGAS00001000982
-
An RCOR1 loss-associated gene expression signature identifies a prognostically significant DLBCL subgroup
Study
EGAS00001001000
-
MutWP1__CRUK_Grand_Challenge_Mutographs_of_Cancer__Colorectal
Study
EGAS00001003774
-
Modeling glioblastoma invasion using human brain organoids and single-cell transcriptomics
Study
EGAS00001003852
-
Whole genome and whole transcriptome sequencing of patients diagnosed with angiosarcoma.
Study
EGAS00001003895
-
Whole genome and transcriptome analysis of anaplastic thyroid carcinoma
Study
EGAS00001001214
-
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas
Study
EGAS00001001916
-
Genome-wide DNA-methylation assessment by MethylCap-seq and Infinium HumanMethylation450 BeadChips: an independent large-scale comparison
Study
EGAS00001001191
-
Integrative_Oncogenomics_of_Multiple_Myeloma
Study
EGAS00001000036
-
Genomics of enteropathy associated T cell lymphoma (EATL)
Study
EGAS00001001954
-
Molecular Attributes Underlying Central Nervous System and Systemic Relapse in Diffuse Large B-cell Lymphoma
Study
EGAS00001004057
-
Reconstruction of complex rearrangement patterns causing the initiation of clear cell renal cell carcinoma.
Study
EGAS00001004015
-
Exome sequence data for germline, primary tumor, and relapse tumor of a transformed non-Hodgkins lymphoma patient with unexpected long-time remission
Study
EGAS00001001973
-
Exome_sequencing_of_EBV_driven_lymphoma
Study
EGAS00001001021
-
Phased whole genome sequencing of 10 melanoma samples
Study
EGAS00001004136
-
Metastatic Adult Pancreatoblastoma: Multimodal Treatment and Molecular Characterization of a Very Rare Disease (NCT MASTER)
Study
EGAS00001004157
-
Integration of genomics and histology reveals diagnosis and effective therapy of refractory cancer of unknown primary with PDL1 amplification (H021)
Study
EGAS00001001846
-
pancreatic ductal adenocarcinoma exomes in study: Pro-immunogenic Impact of MEK inhibition combined with an anti-CD40 immunostimulatory antibody
Study
EGAS00001004196
-
Pancreatic tropism of metastatic renal cell carcinoma
Study
EGAS00001004208
-
Mutation signatures in melanocytic nevi reveal characteristics of defective DNA repair
Study
EGAS00001004274
-
Investigate the evolutionary trajectories during invasiveness acquisition in early lung adenocarcinoma
Study
EGAS00001004754
-
Mutational Landscape of Grey Zone Lymphoma
Study
EGAS00001004482
-
Transcriptomic analysis of the Phase 3 COMPARZ clinical trial
Study
EGAS00001004534
-
Targeted sequencing of Burkitt lymphoma tumour samples from the UK's Haematological Malignancy Research Network
Study
EGAS00001004649
-
Evolutionary dynamics of residual disease in human glioblastoma
Study
EGAS00001003043
-
Rna-Seq Leiomyosarcoma subtypes
Study
EGAS00001004783
-
Clinical Implications of Genomic Alterations in the Tumor and Circulation of Pancreatic Cancer Patients
Study
EGAS00001001257
-
Search for new loci and low-frequency variants influencing glioma risk by exome-array analysis
Study
EGAS00001001258
-
Spatial genomic heterogeneity in multiple myeloma revealed by multi- region sequencing
Study
EGAS00001002111
-
High-resolution structural genomics reveals new therapeutic vulnerabilities in glioblastoma
Study
EGAS00001003493
-
The Genetic Landscape of BCL2 Break Negative Follicular Lymphoma
Study
EGAS00001002164
-
WES used for direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry
Study
EGAS00001002050
-
PLCG1 R707Q mutation is counter selected under targeted therapy in a patient with a hepatic angiosarcoma
Study
EGAS00001001281
-
Transcriptional mechanisms of resistance to anti-PD-1 therapy
Study
EGAS00001002195
-
Circumventing intratumoral heterogeneity to identify potential therapeutic targets in hepatocellular carcinoma. Details please contact lifuqiang@genomics and zhaoxin@genomics.cn.
Study
EGAS00001002207
-
Angiosarcoma_RNA_sequencing
Study
EGAS00001000590
-
Poly(A) RNA sequencing of hepatocellular carcinoma tumors and their matched noncancerous liver tissues
Study
EGAS00001002337
-
Cisplatin increases sensitivity to FGFR inhibition in patient-derived xenograft models of lung squamous cell carcinoma
Study
EGAS00001002423
-
Telomerase activation by genomic rearrangements in high-risk neuroblastoma
Study
EGAS00001001308
-
Recurrent epimutations activate gene body promoters in primary glioblastoma
Study
EGAS00001000685
-
Cell motility and migration as determinants of stem cell efficacy
Study
EGAS00001002478
-
Genomes of Relapsing Neuroblastoma
Study
EGAS00001001387
-
Alternative splicing in Shh-MB
Study
EGAS00001003220